US Pharma MarketingAntheia gets $80M conditional DOD loan to onshore to the US
Antheia lands a conditional $80M loan from the Office of Strategic Capital to build US generic drug manufacturing. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies…
Biosynthesis manufacturer Antheia has won a conditional loan of $80 million from the US Department of Defense to help boost the domestic production of generic drugs.
"Over time, we aim to manufacture Antheia's full pipeline ...
Source: Endpoints News